These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25666701)

  • 1. Combination of Bevacizumab and NGF Reduces the Risk of Diabetic Retinopathy.
    Zhang P; Zhou Z
    Cell Biochem Biophys; 2015 Sep; 73(1):79-85. PubMed ID: 25666701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal Bevacizumab Injection Attenuates Diabetic Retinopathy in Adult Rats with Experimentally Induced Diabetes in the Early Stage.
    Lv J; Chen MM; Mu ZH; Wang F; Qian ZY; Zhou L; Guo QT; Zhao ZM; Pan YP; Liao XY; Yang ZH; Cai N; Li SD; Zou YY
    J Diabetes Res; 2018; 2018():9216791. PubMed ID: 29977927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGF Prevents Loss of TrkA/VEGFR2 Cells, and VEGF Isoform Dysregulation in the Retina of Adult Diabetic Rats.
    Fico E; Rosso P; Triaca V; Segatto M; Lambiase A; Tirassa P
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab Inhibits Angiogenesis and Inflammation in Rat Filtration Surgery Model.
    Cheng G; Xiang H; Yang G; Ma J; Zhao J
    Cell Biochem Biophys; 2015 Sep; 73(1):71-7. PubMed ID: 27352266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
    Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M
    Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effects of bevacizumab eye drops on NGF expression and corneal wound healing in rats.
    Kim EC; Lee WS; Kim MS
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4569-73. PubMed ID: 20393106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular nerve growth factor administration counteracts the impairment of neural precursor cell viability and differentiation in the brain subventricular area of rats with streptozotocin-induced diabetes.
    Tirassa P; Maccarone M; Carito V; De Nicolò S; Fiore M
    Eur J Neurosci; 2015 May; 41(9):1207-18. PubMed ID: 25728260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained and expedited resolution of diabetic papillopathy with combined PRP and bevacizumab.
    Chin EK; Almeida DR; Sohn EH
    Can J Ophthalmol; 2015 Oct; 50(5):e88-91. PubMed ID: 26455990
    [No Abstract]   [Full Text] [Related]  

  • 11. Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab.
    Kubota T; Morita H; Tou N; Nitta N; Tawara A; Satoh H; Shimajiri S
    Retina; 2010 Mar; 30(3):468-72. PubMed ID: 19952991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravitreal bevacizumab on macular and peripapillary choroidal thickness in injected and fellow eyes of patients with diabetic macular oedema.
    Örnek N; Örnek K; Oğurel T; Timur İE
    Acta Ophthalmol; 2015 Dec; 93(8):e684-6. PubMed ID: 25683321
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory effect of intravitreal injection of bevacizumab on nerve growth factor.
    Jee D; Lee WK
    Curr Eye Res; 2012 May; 37(5):408-15. PubMed ID: 22040304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.
    Sawada O; Kawamura H; Kakinoki M; Sawada T; Ohji M
    Arch Ophthalmol; 2007 Oct; 125(10):1363-6. PubMed ID: 17923544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an intravitreal injection of bevacizumab on the expression of VEGF and CD34 in the retina of diabetic rats.
    Ma J; Zhu T; Tang X; Ye P; Zhang Z
    Clin Exp Ophthalmol; 2010 Dec; 38(9):875-84. PubMed ID: 20653693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy.
    Yeh PT; Yang CM; Lin YC; Chen MS; Yang CH
    Retina; 2009 Jun; 29(6):768-74. PubMed ID: 19516117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
    Heier JS; Bressler NM; Avery RL; Bakri SJ; Boyer DS; Brown DM; Dugel PU; Freund KB; Glassman AR; Kim JE; Martin DF; Pollack JS; Regillo CD; Rosenfeld PJ; Schachat AP; Wells JA;
    JAMA Ophthalmol; 2016 Jan; 134(1):95-9. PubMed ID: 26512939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study.
    Cheema RA; Al-Mubarak MM; Amin YM; Cheema MA
    J Cataract Refract Surg; 2009 Jan; 35(1):18-25. PubMed ID: 19101420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of the main constituents of Fufang Xueshuantong Capsules shows protective effects against streptozotocin-induced retinal lesions in rats.
    Jian W; Yu S; Tang M; Duan H; Huang J
    J Ethnopharmacol; 2016 Apr; 182():50-6. PubMed ID: 26692279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.